BIOLINQ - Trademark Details
Status: 638 - New Application - Assigned To Examiner
Image for trademark with serial number 90743811
Serial Number
90743811
Word Mark
BIOLINQ
Status
638 - New Application - Assigned To Examiner
Status Date
2022-02-12
Filing Date
2021-05-30
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
241325 - Other crosses, including ankh, maltese.
Attorney Name
John Paul Oleksiuk
Law Office Assigned Location Code
L90
Employee Name
BIBB, SCOTT
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the word biolinq with a continuous path that forms a cross.
Goods and Services
Wearable monitors use to measure biometric data for medical use; glucose meters; wearable devices for monitoring blood glucose and ketone levels for medical purposes
Classification Information
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2021-08-24
Primary Code
010
Current Trademark Owners
Party Name
Biolinq, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
John Paul Oleksiuk
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Prior Registration6177544
Trademark Events
Event DateEvent Description
2021-06-02NEW APPLICATION ENTERED IN TRAM
2021-08-24NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2021-08-25NOTICE OF DESIGN SEARCH CODE E-MAILED
2021-11-15TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2021-11-15ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2021-11-15TEAS CHANGE OF CORRESPONDENCE RECEIVED
2022-02-12ASSIGNED TO EXAMINER